Nektar Therapeutics | Ventas

Sales Cambio Fecha
Agios Pharmaceuticals USD 7.1M 296K 2023-12
ALKERMES USD 377.48M 3.46M 2023-12
Amgen USD 8.2B 1.29B 2023-12
Baxter International USD 3.88B 177M 2023-12
Biogen USD 2.29B 96.3M 2024-03
Bristol-Myers Squibb USD 11.48B 511M 2023-12
Cipla INR 66.04B 743.4M 2023-12
Dr.Reddys Laboratories INR 72.37B 3.34B 2023-12
Eisai JPY 177.7B 1.09B 2023-12
Eli Lilly USD 9.35B 145.2M 2023-12
Exelixis USD 479.65M 7.73M 2023-12
Gilead Sciences USD 7.12B 64M 2023-12
GlaxoSmithKline GBP 8.05B 95M 2023-12
Grifols EUR 1.77B 172.07M 2023-12
Halozyme Therapeutics USD 230.04M 14.01M 2023-12
Incyte USD 1.01B 94.32M 2023-12
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
Ironwood Pharmaceuticals USD 117.55M 3.81M 2023-12
MacroGenics USD 10.72M 323K 2023-12
Merck USD 14.63B 1.33B 2023-12
Neurocrine Biosciences USD 515.2M 16.4M 2023-12
Novartis USD 11.83B 54M 2024-03
Pfizer USD 14.25B 1.02B 2023-12
Roche Holding CHF 28.94B 842M 2023-12
Sarepta Therapeutics USD 396.78M 64.96M 2023-12
Takeda JPY 1.11T 68.1B 2023-12
Teva Pharmaceutical Industries USD 4.46B 607M 2023-12
Xencor USD 44.69M 14.48M 2023-12



Nektar Therapeutics Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2024.